Answers are grounded in this paper and cite their sources.
Expert discussion highlights care management strategies and novel therapies for multiple myeloma patients, indicating improved access in remote areas.
Novel, highly effective therapies for multiple myeloma are raising hopes, while also adding complexity to treatment decisions and care management. Recently, Canadian Hematology Today sat down with two Canadian experts and discussed what the availability of novel therapies means for patients, and how clinical leaders are coordinating care to improve access for patients in Northern Ontario.
No takes yet. Share an insight, caveat, or question.
McCurdy et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: